TORONTO – April 20, 2005 – A slew of recent evidence and rare US and international patents have accelerated research on one of the body’s chief defenses against illness, the essential, yet little-known protein, glutathione (GSH). Medical patents for natural health interventions are few and far between in the world of chemically-based drugs.
“In the next five or six years, people are going to be using the word glutathione as commonly as they use the word vitamin C or antioxidant,” says Dr. Jimmy Gutman, a Montreal-based physician and author of “GSH, Your Body’s Most Powerful Protector, Glutathione”.
“Glutathione is virtually involved in dozens of critical cell processes and without it we would succumb to our environment literally within hours,” says Gutman.
Drawing on his experience as an academic, clinician and former Undergraduate Director of Emergency Medicine at McGill University, Gutman has shifted his focus to concentrate on the research and clinical application of glutathione. McGill has been a leader in the research of this essential molecule for more than two decades.
Among the most compelling findings to date is the “very fantastic research” pertaining to the universal disease, aging, and the consequences of the inevitable drop in GSH levels seen in age-related diseases.
In essence, GSH is a tripeptide made up of three amino acids, including the difficult-to-obtain cysteine. Its superior function lies in its frontline defence against infection and the daily bombardment of environmental toxins. It’s potent anti-oxidant and anti-viral properties are now highly recognized.
Although GSH was first discovered in 1888, it has been slow to surface on the medical radar screen. Because of scarce funding, coupled with little interest or awareness by the medical community, the role that glutathione plays in cell metabolism has been highly overlooked.
That is changing. Compared to a few dozen research publications in the 1970s, today there are more than 60,000 medical articles published on glutathione.
While the evidence clearly supports the role of GSH, the difficulty lies in obtaining adequate levels to combat illness and maintain health. The essential precursors of GSH must be able to make it from the mouth to the gut then through the cells walls. There lies the challenge.
According to Gutman, “At some point we all drop our levels of life- enhancing GSH. There’s a constant demand for glutathione and the precursors or building blocks are getting rarer in the average North American diet.”
A very simple cysteine-rich protein extracted from milk may provide the catalyst to raising GSH levels.
Martin Joynes, a semi-retired researcher, experienced hands-on evidence of the power of raising his GSH levels. For years, Joynes suffered from chronic fatigue syndrome and fibromyalgia that countless medical practitioners were not able to recognize nor treat.
When Joynes became so debilitated that he considered purchasing a walker or a wheel chair by his early 50s, he decided to take charge of his own health. After doing extensive research, then boosting his GSH levels, he regained his mobility and natural high energy. “Within a week, I realized I didn’t hurt anymore,” says Joynes. “I just got better and better. It was so simple and so astounding.”
Joynes has never looked back. Today, he continues to maintain his GSH levels, is vibrant and healthy, and “rarely gets a cold.”
Gutman is not surprised by Joynes’s experience. “Doctors are the last ones to really be on top of nutrition or supplements,” says Gutman. “But you’re going to see a paradigm shift towards using whatever is available that stands up to scientific rigor and clinical tests.”
Source: Pharmalive.com (http://www.pharmalive.com/News/index.cfm?articleid=231245&categoryid=15)
© 2005 Engel Publishing Partners